BridgeBio Pharma, Inc. · NASDAQ:BBIO

BridgeBio Pharma, Inc. shareholders

As of Sep 30, 2026, 458 institutions reported holding BridgeBio Pharma, Inc., 98.5% of its shares. Largest: Vanguard, Janus Henderson and Farallon Capital Management, L.L.C. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of BridgeBio Pharma, Inc.ChangeFiled
Vanguard16.8M8.6%−135KNov 16, 2026
Janus Henderson14.6M7.5%first reportNov 16, 2026
Farallon Capital Management, L.L.C.14.2M7.3%+3.5MNov 16, 2026
BlackRock10.4M5.3%+102KNov 13, 2026
Viking Global Investors LP9.79M5.0%−157KNov 16, 2026
Wellington9.46M4.9%+4.15MNov 16, 2026
Kohlberg Kravis Roberts & Co. L.P.8.26M4.2%−5MNov 13, 2026
State Street4.98M2.6%+541KNov 12, 2026
Invesco4.32M2.2%+616KNov 12, 2026
Franklin Templeton4.15M2.1%+995KNov 12, 2026

BridgeBio Pharma, Inc. insider trades